Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma

Figure 2

Effect of MMP-2 and TIMP-2 immunoreactive protein combinations on the cancer-specific survival in endometrioid adenocarcinoma patients.